Use of paf - antagonists against the new design of paf - binding sites on endothelial cells for the treatment or prevention of the hyperinsulinism

摘要

use of substances, the newly trained endothelial paf - binding sites inhibit or the new training of endothelial paf - binding sites to counteract or the retraining to prevent.